• Mallinckrodt logo

     
     

    Ocera Therapeutics is now a part of Mallinckrodt

    To learn more about our development product OCR-002 (l-ornithine phenylacetate), visit our pipeline page.

     

    To learn more about Mallinckrodt, click here.  

      
    Ocera
    Privacy Policy  Terms of Use  Patents